Why START? Reflections that led to the conduct of this large long-term strategic HIV trial
Document Type
Journal Article
Publication Date
4-2015
Journal
HIV Medicine
Volume
16
Issue
suppl. 1
Inclusive Pages
1-9
DOI
10.1111/hiv.12227
Keywords
Anti-Retroviral Agents--therapeutic use; Antiretroviral Therapy, Highly Active--methods; HIV Infections--drug therapy
APA Citation
The INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group*, & Kan, V. (2015). Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine, 16 (suppl. 1). http://dx.doi.org/10.1111/hiv.12227
Peer Reviewed
1
Open Access
1
Comments
This is an open access PubMed Central article. Click on link for full-text access.